Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yutiq in chronic non-infectious posterior uveitis
NCT01694186Phase 3Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of fluocinolone in non-infectious posterior uveitis (NIPU), sponsored by EyePoint Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
fluocinolone
03
Conditions
non-infectious posterior uveitis (NIPU)
Beyond the preview
Go deeper on NCT01694186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694186.